Pharmacogenomics
What is Pharmacogenomics?
It is the study of an individual's genetic information and reaction or response to certain drugs.
The idea behind Pharmacogenomics is that one day you will have a personalized drug treatment for everything. You will know whether Alieve, Advil, or Tylnol works best for your pain relief, based on your genetic make-up.
The hope is that doctors and scientists, working together will create better (more powerful) and safer drugs based on your personal genetic makeup. It is hoped that by honing in on certain diseases that attack certain cells, in relation to certain genes, there will be fewer side-effects for patients.
In the future, doctors will be able to look at a map of your genes and determine what drug will work best for you, without the trial-and-error method.
Pharmacogenomics will also allow for the advanced screening for diseases which will allow individuals at an early age to make adequate changes to their lifestyle and environment which may allow the patient to avoid or lessen the severity of a genetic disease.
Pharmacogenomics is still in its infant stages of development, and is mostly used in drug trials by pharmaceutical companies to determine the likelihood of the breakdown of their drugs by certain enzymes created by certain genes.
For more information on the technology and complexity behind pharmacogenomics, please visit this sister site that provides a more biological and structural look at the Human Genome Project
It is the study of an individual's genetic information and reaction or response to certain drugs.
The idea behind Pharmacogenomics is that one day you will have a personalized drug treatment for everything. You will know whether Alieve, Advil, or Tylnol works best for your pain relief, based on your genetic make-up.
The hope is that doctors and scientists, working together will create better (more powerful) and safer drugs based on your personal genetic makeup. It is hoped that by honing in on certain diseases that attack certain cells, in relation to certain genes, there will be fewer side-effects for patients.
In the future, doctors will be able to look at a map of your genes and determine what drug will work best for you, without the trial-and-error method.
Pharmacogenomics will also allow for the advanced screening for diseases which will allow individuals at an early age to make adequate changes to their lifestyle and environment which may allow the patient to avoid or lessen the severity of a genetic disease.
Pharmacogenomics is still in its infant stages of development, and is mostly used in drug trials by pharmaceutical companies to determine the likelihood of the breakdown of their drugs by certain enzymes created by certain genes.
For more information on the technology and complexity behind pharmacogenomics, please visit this sister site that provides a more biological and structural look at the Human Genome Project
posted by Alana at 2:32 PM
0 Comments:
Post a Comment
<< Home